GPs are set to play a key role in delivering care for people with mild and moderate ME/CFS under a new delivery plan.

A new framework published in JAMA Internal Medicine offers a systematic approach to this challenge. Researchers described the ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

To address the gap in sepsis management bundle compliance at a community hospital in Cleveland, Ohio, the authors created an intervention targeting patients who presented with sepsis upon admission, ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a Strong Buy.

Wes Streeting is expected to unveil the 10-year plan for the NHS soon (Lucy North/PA) Money for hospitals could be linked to patient ratings under new plans for the NHS, a report has suggested.

Labour’s NHS plan lacks the detail to make any verdict on whether it will succeed experts say ...

Sir Keir Starmer unveils 10-year plan for the NHS and declares: 'The future already looks better' The prime minister said there is "a lot more work to do" to improve the NHS, but praised ...

Therapists are cautious about sharing personal information. When they fall ill or die unexpectedly, the shock can be ...

Money for hospitals could be linked to patient ratings under new plans for the NHS, a report has suggested. The 10-year plan for the NHS is due to be announced next week, as ministers have said ...

First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease - XC001 is a novel investigational therapy that previously ...